gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · OFIXHealthcareSurgical Instruments

Orthofix Medical Inc. Common Stock (DE) (OFIX)

$9.72+10.96%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$9.72▼ 34.63% in range
Nov 4, 2025Low $8.64 · High $16.20Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Orthofix Medical Inc. Common Stock (DE) closed at $9.72 on Nov 4, up 10.96%, 40.0% below its 52-week closing high. Volume of 1.2M shares was 3.06× its 20-day average (well above normal).

Split-adjusted performance: +3.3% over one month, -20.3% over six months, -39.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $210.93M, up 3.8% from a year earlier, with a net margin of -7.5%.

Short interest was 2.4M shares at the Oct 15 settlement, down 2.1% from the prior report (6.1% of float, 5.8 days to cover).

Market cap$395.9M40.7M shares
Revenue · quarter$210.9M+3.8% YoY
Diluted EPS$-0.39—
P/E · TTM—P/S 0.5×
Net margin-7.5%Gross 71.0%
Dividend yieldNone
52-week range8.64 – 16.20−40.0% from high
Volume1.2M3.06× 20-day avg
Volatility · 60d47.1%Annualised
Short % of float6.1%5.8 days to cover
Net cash-$130.8MCash $103.8M
Next earnings—Not scheduled
Split-adjusted performance
1W −3.2%1M +3.3%3M −8.3%6M −20.3%YTD −35.9%1Y −39.5%3Y −11.9%5Y −72.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum36
Revenue growth36
Net margin51
Value (low P/E)—
Size54

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short2.4M−2.1% vs prior
Days to cover5.8Settled Oct 15
% of float6.1%
Short vol. 10d42.9%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
OFIXOrthofix Medical Inc. Common Stock (DE)$9.72+10.96%−20.3%+3.8%−7.5%—$395.9M
MOBIMobia Medical$11.24+12.74%——−155.8%—$374.2MCompare
EMBCEmbecta$6.52+7.24%+83.1%−8.1%7.8%4.2$369.4MCompare
OBIOOrchestra BioMed Holdings$6.00+7.91%+46.0%−89.5%−27362.5%—$360.6MCompare
SIShoulder Innovations$21.01+6.00%+63.0%—−59.1%—$437.4MCompare
CARLCarlsmed$16.09+11.74%+63.5%—−55.5%—$439.3MCompare
SSIISS Innovations International$2.27−2.58%−44.2%+39.4%−19.1%—$455.1MCompare
NPCENeuropace$13.34+8.37%−26.4%+17.1%−27.2%—$457.9MCompare
MDXGMiMedx Group$3.20−1.54%−12.6%−45.2%−13.9%—$467.0MCompare

News about Orthofix Medical Inc. Common Stock (DE)

All news →

No recent articles focused on Orthofix Medical Inc. Common Stock (DE). 1 articles mention it in passing.

Quick answers

What does Orthofix Medical Inc. Common Stock (DE) do?
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers.
What is OFIX's market cap?
$395.92M, based on the Nov 4 close of $9.72.
Does Orthofix Medical Inc. Common Stock (DE) pay a dividend?
No regular cash dividend has been paid in the last year.
How much of OFIX is sold short?
2.4M shares, 6.1% of float, as of Oct 15, 2026.
What sector is OFIX in?
Healthcare, in the Surgical Instruments industry.

About Orthofix Medical Inc. Common Stock (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

HQ: Lewisville, TX1,605 employeesListed Apr 24, 1992orthofix.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology